Aube

Evidence · Not just promises

Research

A real role. The right evidence.

The value of a supplement is not the story on its label. It is what a well-studied ingredient can do, for whom, and under which conditions. Here is the research that informs our approach—positive findings, practical context and limits included.

Themes
04
Studies
14

These publications study nutrients, exercise or health markers—not finished Aube products. We do not present them as clinical trials of our formulations.

What makes evidence useful.

Not every result carries the same weight. Our reading starts with three questions.

01

Who was studied?

Age, baseline nutrient status and lifestyle determine how relevant a finding is to you.

02

What actually changed?

A blood marker, a strength test and a clinical health outcome are different things. We keep that distinction visible.

03

How certain is it?

Randomised trials help assess effects; systematic reviews compare the wider evidence. Neither removes the need to consider quality and limitations.

Sleep

Recovery first. Magnesium research is promising, but not a licence to promise better sleep.

04 studies

Our perspective

For Aube, the opportunity is targeted nutritional support within a real recovery routine—not selling a shortcut to sleep.

  1. R.01
    Systematic review2010

    Sleep duration and all-cause mortality: a systematic review and meta-analysis

    Cappuccio et al. · Sleep

    Study context

    Prospective population studies examining sleep duration and mortality.

    The finding

    Both short and long sleep were associated with higher mortality. Sleep deserves a place among the foundations of long-term health.

    What it does not prove

    Association is not causation: illness and other lifestyle factors can influence sleep. This is not evidence for a supplement.

    Read publication
  2. R.02
    Narrative review2015

    Sleep and athletic performance: the effects of sleep loss on exercise performance and physiological responses to exercise

    Fullagar et al. · Sports Medicine

    Study context

    Review of experimental research on sleep loss, exercise and recovery.

    The finding

    Sleep loss can affect performance, perceived effort and physiological recovery. A consistent sleep routine supports the work done in training.

    What it does not prove

    Responses vary by task and degree of sleep loss. A narrative review does not establish the efficacy of sleep supplements.

    Read publication
  3. R.03
    Randomised controlled trial2012

    The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled trial

    Abbasi et al. · Journal of Research in Medical Sciences

    Study context

    46 older adults with primary insomnia; eight weeks of magnesium or placebo.

    The finding

    Improvements were reported in several subjective sleep measures, including sleep onset and insomnia severity. An encouraging signal worth investigating.

    What it does not prove

    A small, specific population and a different formulation. This trial does not prove that Aube magnesium treats insomnia.

    Read publication
  4. R.12
    Systematic review2021

    Oral magnesium supplementation for insomnia in older adults: a systematic review & meta-analysis

    Mah & Pitre · BMC Complementary Medicine and Therapies

    Study context

    Three randomised trials, 151 older adults; the sleep-onset analysis pooled two trials.

    The finding

    Pooled sleep-onset time was about 17 minutes shorter with magnesium than placebo. Total sleep time did not improve significantly.

    What it does not prove

    Low to very low certainty and small trials. Sleep benefits remain preliminary, not a guaranteed effect or a treatment recommendation.

    Read publication

Strength

Where supplementation has a clear role: supporting the work your muscles already do.

03 studies

Our perspective

Creatine and protein have a practical place alongside resistance training. The benefit depends on the routine, nutritional needs and consistency.

  1. R.04
    Meta-analysis2003

    Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance

    Rawson & Volek · Journal of Strength and Conditioning Research

    Study context

    22 studies comparing creatine plus resistance training with placebo plus training.

    The finding

    Average strength gains were 20% with creatine versus 12% with placebo: an 8-percentage-point difference. Supplementation can add to training adaptations.

    What it does not prove

    Study protocols and responses differed. These averages are not individual predictions; creatine complements training rather than replacing it.

    Read publication
  2. R.05
    Systematic review2018

    A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults

    Morton et al. · British Journal of Sports Medicine

    Study context

    49 randomised trials, 1,863 healthy adults completing resistance training.

    The finding

    Protein supplementation added an average 0.30 kg of fat-free mass and 2.49 kg to one-repetition-maximum strength compared with controls. A practical way to fill a protein gap.

    What it does not prove

    Average effects were modest and depended on total protein intake and training. The analysis covered different protein sources, not Aube whey specifically.

    Read publication
  3. R.06
    Meta-analysis2010

    Resistance exercise for muscular strength in older adults: a meta-analysis

    Peterson et al. · Ageing Research Reviews

    Study context

    Intervention studies assessing resistance exercise in older adults.

    The finding

    Resistance training improved muscular strength in older adults. The primary stimulus is the training itself; nutrition supports the ability to sustain it.

    What it does not prove

    Exercise evidence is not supplement evidence. Programmes, baseline fitness and participant characteristics differed.

    Read publication

Nutrition

Useful nutrients. Specific needs. Evidence that deserves more than a headline.

05 studies

Our perspective

Vitamin D, vitamin K and magnesium matter to normal physiology. Supplementation makes sense when it meets a relevant need; a clinical finding is not a universal promise.

  1. R.07
    Systematic review2014

    Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis

    Reid et al. · The Lancet Diabetes & Endocrinology

    Study context

    23 studies, 4,082 participants; bone mineral density assessed at several skeletal sites.

    The finding

    A small benefit appeared at the femoral neck, but not consistently across other sites. Nutrient status matters more than assuming everyone needs extra vitamin D.

    What it does not prove

    Bone density is a surrogate marker, not a direct fracture outcome. Results do not justify universal supplementation for stronger bones.

    Read publication
  2. R.08
    Randomised controlled trial2015

    Menaquinone-7 supplementation improves arterial stiffness in postmenopausal women

    Knapen et al. · Thrombosis and Haemostasis

    Study context

    244 healthy postmenopausal women; MK-7 or placebo for three years.

    The finding

    MK-7 improved selected measures of arterial stiffness, with benefits particularly apparent in women with higher stiffness at baseline.

    What it does not prove

    A specific population and surrogate outcomes. This does not establish prevention of cardiovascular events or prove the efficacy of a D3 + K2 combination.

    Read publication
  3. R.09
    Systematic review2019

    Carbohydrate quality and human health: a series of systematic reviews and meta-analyses

    Reynolds et al. · The Lancet

    Study context

    Observational research and clinical trials examining fibre and whole-grain intake.

    The finding

    Higher fibre intake was associated with better long-term health outcomes; trials also showed improvements in selected cardiometabolic markers. Food quality remains the starting point.

    What it does not prove

    Observational associations cannot establish causality alone. These findings concern dietary patterns, not the efficacy of a particular fibre supplement.

    Read publication
  4. R.13
    Meta-analysis2016

    Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials

    Zhang et al. · Hypertension

    Study context

    34 trials, 2,028 participants; median study duration of three months.

    The finding

    Average reductions were 2.00 mmHg systolic and 1.78 mmHg diastolic versus placebo. A measurable, modest effect—not a dramatic transformation.

    What it does not prove

    Doses, formulations and baseline health varied. These results do not make magnesium a substitute for blood-pressure treatment or prove an effect at the Aube label dose.

    Read publication
  5. R.14
    Randomised controlled trial2022

    Supplemental vitamin D and incident fractures in midlife and older adults

    LeBoff et al. · New England Journal of Medicine

    Study context

    VITAL ancillary study: 25,871 adults not selected for vitamin D deficiency or osteoporosis.

    The finding

    Vitamin D3 did not significantly reduce fractures compared with placebo. The strongest rationale for supplementation is a relevant need—not a promise that more is always better.

    What it does not prove

    This was not a trial specifically treating clinical deficiency. Null results in an unselected population do not settle every deficiency-related question.

    Read publication

Measure

Health is more than an ingredient. Keep the wider system in view.

02 studies

Our perspective

Training, food, sleep and appropriate clinical follow-up remain the foundations. Supplements support that system; they do not replace it.

  1. R.10
    Meta-analysis2009

    Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events

    Kodama et al. · JAMA

    Study context

    Prospective cohort studies relating cardiorespiratory fitness to subsequent health outcomes.

    The finding

    Higher fitness was associated with lower all-cause mortality and cardiovascular event risk. Functional capacity is an important part of the healthspan picture.

    What it does not prove

    Observational evidence cannot prove that changing one fitness measure causes a specific reduction in risk. No supplement was tested.

    Read publication
  2. R.11
    Cohort study2018

    Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing

    Mandsager et al. · JAMA Network Open

    Study context

    122,007 adults undergoing exercise treadmill testing; retrospective follow-up.

    The finding

    Greater cardiorespiratory fitness was associated with lower long-term mortality. Measuring function helps put a routine into context beyond how it feels.

    What it does not prove

    A referred clinical cohort, not a randomised intervention. The study cannot establish that supplements improve survival.

    Read publication

Evidence before excess.

Choose a supplement for a reason, not for a promise. Explore the collection for each product’s composition, label directions and published references—and keep sleep, movement and food at the centre.

Explore Aube products

Educational information, not individual medical advice. Findings apply to the populations and protocols studied. No supplement here is presented as a treatment or a guarantee of longer life.

Continue exploring

Products

Targeted supplements, fully disclosed.

Healthspan

Rest, strength and nutrition.

Protocol

Less improvisation. More consistency.